Is Non-treatment Related Anorexia in Cancer Patients Promoted by Subclinical Micronutrient Deficiencies?

References

• Holmes S, Dickerson J WT. Malignant disease: nutritional implications of disease and treatment. Cancer Metast Review 1987; 6: 357–81
   PubMed Web of Science ®Google Scholar
• Calman K C. Cancer cachexia. Br J Hosp Med 1982; 27: 28–34
   PubMed Web of Science ®Google Scholar
• Wangel A G, Deller D J. Malabsorption syndrome associated with carcinoma of the bronchus. Gut 1966; 6: 73–6
   Web of Science ®Google Scholar
• Creamer B. Malignancy and the small intestinal mucosa. Br Med J 1964; 2: 1435–6
   PubMedGoogle Scholar
• Blackburn G L, Bothe A. Assessment of malnutrition in cancer patients. Cancer Bull 1978; 30: 88–93
   Google Scholar
• DeWys W D. Nutritional care of the cancer patient. JAMA 1980; 244: 374–6
   PubMed Web of Science ®Google Scholar
• Harvey K B, Bothe A, Blackburn G L. Nutritional assessment and patient outcome during oncological therapy. Cancer 1979; 43: 2065–9
   PubMed Web of Science ®Google Scholar
• Sweet D L, Kimnaley A, Ultman J L. Hodgkin's disease: problems of staging. Cancer 1978, Suppl: 947–71
   Google Scholar
• Hoffman F A. Micronutrient requirements of cancer patients. Cancer 1985; 55: 295–300
   PubMed Web of Science ®Google Scholar
• Department of Health and Social Security. Recommended daily amounts of food energy and nutrients for groups of people in the United Kingdom. HMSO, London 1979, Report on Health and Social Subjects No. 15
   Google Scholar
• Mervyn L. Complete guide to vitamins and minerals. Thorsons, Wellingborough 1986
   Google Scholar
• Holford P. The ION Survey. Institute for Optimum Nutrition, London 1986
   Google Scholar
• Institute for Optimum Nutrition. The vitamin controversy. Institute for Optimum Nutrition, London 1987
   Google Scholar
• Bertino J R. Nutrients, vitamins and minerals as therapy. Cancer 1979; 43: 1655–60
   Web of Science ®Google Scholar
• Calman K C. Nutritional support in malignant disease. Proc Nutr Soc 1978; 37: 87–93
   PubMed Web of Science ®Google Scholar
• Cutler E A, Palmer J, Kontras S B. Chemotherapy and possible zinc deficiency. N Eng J Med 1977; 297: 168–9
   PubMed Web of Science ®Google Scholar
• Krasner N, Dymock I. Ascorbic acid deficiency in malignant diseases: a clinical and biochemical study. Br J Cancer 1974; 30: 142–5
   PubMed Web of Science ®Google Scholar
• Anthony H, Schorah C J. Severe hypovitaminosis C in lung cancer patients: the utilisation of vitamin C in surgical repair and lymphocyte host resistance. Br J Cancer 1982; 46: 354–7
   PubMed Web of Science ®Google Scholar
• Basu T K, Raven R W, Dickerson J WT, Williams D C. Leukocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast tumour with skeletal metastases. Eur J Cancer 1974; 10: 507–11
   PubMed Web of Science ®Google Scholar
• Poulter J M, White W F, Dickerson J WT. Ascorbic acid supplementation and five-year survival rates in women with early breast cancer. Acta Vitamin Enzym 1985; 6: 175–82
   Google Scholar
• Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer prolonging survival in terminal human cancer. Proc Nat Acad Sci 1976; 73: 3685–9
   PubMed Web of Science ®Google Scholar
• Creagan E T, Moertel C G, O'Fallon J R, Schult A J, O'Connell M J, Rubin J, Frytak F. Failure of high dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. N Engl J Med 1979; 301: 687–90
   PubMed Web of Science ®Google Scholar
• Davies S, Stewart A. Nutritional medicine. Pan Books, London 1987
   Google Scholar
• Marks J A. A guide to the vitamins. Medical and Technical Publishing Co. Ltd., London 1975
   Google Scholar
• Pauling L. How to live longer and feel better. W.H. Freeman and Company, New York 1986; 170–1
   Google Scholar
• Aksoy M, Basu T K, Brient J, Dickerson J WT. Thiamine status of patients treated with drug combinations containing 5-fluorouracil. Eur J Cancer 1980; 16: 1041–5
   Web of Science ®Google Scholar
• Basu T K, Dickerson J WT. The thiamine status of early cancer patients with particular reference to those with breast and bronchial carcinoma. Oncology 1976; 33: 250–2
   PubMed Web of Science ®Google Scholar
• Mooradian A D, Morley J E. Micronutrient status in diabetes mellitus. Am J Clin Nutr 1987; 45: 877–95
   PubMed Web of Science ®Google Scholar
• Marks P A, Bishop J S. The glucose metabolism of patients with malignant disease and of normal subjects as studied by means of an intravenous glucose tolerance test. J Clin Invest 1957; 36: 254–7
   PubMed Web of Science ®Google Scholar
• Lundholm K, Bylund A C, Shersten T. Glucose metabolism in relation to skeletal muscle enzyme activities in cancer patients. Scand J Clin Invest 1977; 37: 267–72
   PubMed Web of Science ®Google Scholar
• Bishop J S, Marks P A. Studies on carbohydrate metabolism in patients with neoplasia. Studies II Response to insulin administration. J Clin Invest 1959; 38: 668–72
   PubMed Web of Science ®Google Scholar
• Lundholm K, Holm G, Shersten T. Insulin resistance in patients with cancer. Cancer Res 1978; 38: 4665–70
   PubMed Web of Science ®Google Scholar
• DeWys W D, Pories W. Inhibition of a spectrum of animal tumours by dietary zinc deficiency. J Natl Cancer Inst 1972; 48: 375–81
   PubMedGoogle Scholar
• Bates J, McClain C. The effect of severe zinc deficiency on serum levels of albumin, transferrin and prealbumin in man. Am J Clin Nutr 1981; 34: 1655–60
   PubMed Web of Science ®Google Scholar
• Hambidge K M, Hambidge C, Jacobs M, Baum J D. Low levels of zinc in hair, anorexia and poor growth and hypogeusia in children. Paediat Res 1972; 6: 868–76
   PubMed Web of Science ®Google Scholar
• Cavalieri R R. Trace elements. Modern nutrition in health and disease. 6th ed., R S Goodhart, M E Shils. Lea and Febiger, Philadelphia 1980; 395–441
   Google Scholar
• Park J H, Grandjean C J, Hart M H, Erdman S H, Pour P, Vanderhoof J A. Effects of pure zinc deficiency on glucose tolerance and insulin and glucagon levels. Am J Physiol (Part 1) 1986; 251: 273–8
   Google Scholar
• Gums J. Clinical significance of magnesium - a review. Drug Intelligence and Clinical Pharmacy 1987; 21: 240–6
   PubMedGoogle Scholar
• Soukop M, Calman K C. Nutritional support in patients with a malignant disease. J Hum Nutr 1979; 33: 179–88
   PubMedGoogle Scholar
• Braverman E R, Pfeiffer C C. Essential trace elements and cancer. J Orth Psych 1982; 11: 28–41
   Google Scholar
• Riales R, Albrink M J. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein in adult man. Am J Clin Nutr 1981; 34: 2670–9
   PubMed Web of Science ®Google Scholar
• Hanck A. Vitamin C and cancer. Int J Vit Nutr Res 1983, Supplement No. 24, In: Hanck A Vitamins in medicine: recent therapeutic aspects
   Google Scholar
• Morishige F, Nakamura T, Nakamura N, Morishige N. The role of vitamin C in tumor therapy (human). Vitamins and cancer-human cancer prevention by vitamins and micronutrients, F L Meyskens, K N Prasad. Humana Press Inc., New Jersey 1985; 399–427
   Google Scholar
• Pitts F N, Jr. The biochemistry of anxiety. Scientific American Feb., 1969; 69–75
   PubMed Web of Science ®Google Scholar
• Urberg M, Zemel M B. Evidence for synergism between chromium and nicotinic acid in the control of glucose tolerance in elderly humans. Metabolism 1987; 36: 896–9
   PubMed Web of Science ®Google Scholar